Gujarat Terce Laboratories Ltd

₹ 34.9 4.71%

24 Jul - close price

About

Incorporated in 1985. Gujarat Terce Laboratories Ltd is engaged in development, manufacturing, marketing and distribution of medicines, healthcare products and branded generics

Key Points

Product Profile:^[1]
Company has an extensive basket of 50 Brands (125 products) with a portfolio contributing to
10 therapeutic areas, covering multiple dosage forms like Tablets, Capsules, Oral Liquids, Ointments and Injectables.

Website BSE

Market Cap ₹ 27.2 Cr.
Current Price ₹ 34.9
High / Low ₹ 59.8 / 29.0
Stock P/E 10.9
Book Value ₹ 12.5
Dividend Yield 0.00 %
ROCE 39.8 %
ROE 30.7 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Cons

Company has a low return on equity of 7.95% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	12.89	10.72	12.03	13.02	12.21	11.89	13.30	12.68	12.32	10.85	12.93	12.29	11.40
	13.08	11.85	11.48	12.18	11.20	11.81	11.64	11.60	11.27	10.86	11.03	11.16	10.66
Operating Profit	-0.19	-1.13	0.55	0.84	1.01	0.08	1.66	1.08	1.05	-0.01	1.90	1.13	0.74
OPM %	-1.47%	-10.54%	4.57%	6.45%	8.27%	0.67%	12.48%	8.52%	8.52%	-0.09%	14.69%	9.19%	6.49%
	0.10	0.08	0.08	0.08	0.08	0.07	0.08	0.07	0.09	0.09	0.05	0.13	-0.37
Interest	0.17	0.17	0.20	0.16	0.15	0.13	0.13	0.08	0.07	0.05	0.07	0.04	0.03
Depreciation	0.16	0.09	0.09	0.09	0.09	0.09	0.09	0.10	0.10	0.10	0.10	0.10	0.13
Profit before tax	-0.42	-1.31	0.34	0.67	0.85	-0.07	1.52	0.97	0.97	-0.07	1.78	1.12	0.21
Tax %	-290.48%	0.00%	0.00%	0.00%	35.29%	14.29%	1.97%	-3.09%	449.48%	-42.86%	21.35%	33.04%	47.62%
	0.80	-1.31	0.33	0.67	0.54	-0.08	1.48	1.01	-3.39	-0.04	1.40	0.76	0.10
EPS in Rs	1.08	-1.77	0.44	0.90	0.73	-0.11	1.99	1.36	-4.57	-0.05	1.89	0.98	0.13
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	26.48	25.00	25.29	29.01	31.03	37.54	25.18	40.13	46.78	47.92	50.20	47.47
	25.70	24.84	25.21	28.68	30.54	36.86	27.77	39.02	48.94	46.65	46.31	43.72
Operating Profit	0.78	0.16	0.08	0.33	0.49	0.68	-2.59	1.11	-2.16	1.27	3.89	3.75
OPM %	2.95%	0.64%	0.32%	1.14%	1.58%	1.81%	-10.29%	2.77%	-4.62%	2.65%	7.75%	7.90%
	0.08	0.19	0.44	0.41	0.32	0.29	0.62	0.31	0.35	0.32	0.31	-0.11
Interest	0.41	0.38	0.31	0.23	0.25	0.29	0.39	0.40	0.72	0.68	0.42	0.18
Depreciation	0.16	0.19	0.19	0.19	0.21	0.24	0.18	0.28	0.36	0.37	0.38	0.42
Profit before tax	0.29	-0.22	0.02	0.32	0.35	0.44	-2.54	0.74	-2.89	0.54	3.40	3.04
Tax %	72.41%	209.09%	150.00%	15.62%	-25.71%	36.36%	-0.39%	-17.57%	-42.21%	55.56%	128.53%	27.30%
	0.09	-0.67	-0.01	0.27	0.43	0.28	-2.52	0.87	-1.67	0.24	-0.98	2.20
EPS in Rs	0.12	-0.90	-0.01	0.36	0.58	0.38	-3.40	1.17	-2.25	0.32	-1.32	2.82
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	7%
5 Years:	14%
3 Years:	0%
TTM:	-5%

Compounded Profit Growth
10 Years:	19%
5 Years:	25%
3 Years:	52%
TTM:	352%

Stock Price CAGR
10 Years:	14%
5 Years:	25%
3 Years:	9%
1 Year:	-30%

Return on Equity
10 Years:	-1%
5 Years:	3%
3 Years:	8%
Last Year:	31%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	7.42	7.42	7.42	7.42	7.42	7.42	7.42	7.42	7.42	7.42	7.42	7.79
Reserves	3.61	2.94	2.64	2.98	3.41	3.69	0.24	1.11	-0.56	-0.31	-0.94	1.94
	8.21	7.13	7.00	0.37	0.68	2.60	4.74	6.67	7.27	3.87	0.94	1.30
	7.06	6.98	6.59	8.69	7.94	8.80	9.47	12.19	14.39	12.29	15.41	13.52
Total Liabilities	26.30	24.47	23.65	19.46	19.45	22.51	21.87	27.39	28.52	23.27	22.83	24.55
	6.48	6.34	6.17	1.88	2.06	2.29	2.45	4.29	3.99	3.69	3.65	3.25
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.30	0.30	0.24	0.27	0.29	0.27	0.27	0.27	0.27	0.27	0.52	1.35
	19.52	17.83	17.24	17.31	17.10	19.95	19.15	22.83	24.26	19.31	18.66	19.95
Total Assets	26.30	24.47	23.65	19.46	19.45	22.51	21.87	27.39	28.52	23.27	22.83	24.55

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1.38	0.16	0.24	4.58	-0.61	-1.59	-0.16	-0.44	0.03	2.60	3.06	1.71
	0.08	-0.13	0.18	1.11	-0.13	-0.27	-0.42	-0.87	0.62	-0.46	0.46	-0.11
	-0.73	-1.43	-0.36	-5.39	0.20	1.72	1.83	1.53	-0.12	-4.08	-2.83	0.47
Net Cash Flow	0.73	-1.39	0.06	0.29	-0.55	-0.14	1.24	0.22	0.52	-1.94	0.69	2.08
Free Cash Flow	0.92	0.10	0.23	4.45	-1.01	-2.07	-0.66	-2.55	-0.03	2.53	3.41	1.69
CFO/OP	191%	406%	688%	1,418%	-98%	-219%	0%	-31%	-3%	205%	81%	46%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	126.81	123.81	114.31	57.62	53.29	68.16	74.94	49.75	62.34	43.11	36.86	37.45
Inventory Days	142.73	162.86	150.01	126.33	114.69	90.00	136.65	153.90	83.56	81.09	71.03	79.48
Days Payable	88.41	92.30	59.70	110.67	85.26	83.44	104.13	96.22	110.35	97.39	69.87	33.67
Cash Conversion Cycle	181.14	194.37	204.61	73.29	82.72	74.72	107.46	107.43	35.56	26.81	38.02	83.26
Working Capital Days	97.04	110.52	86.74	20.89	27.88	25.18	-14.06	6.82	-20.21	-7.69	-13.89	4.61
ROCE %	3.39%	0.87%	1.91%	2.95%	5.39%	5.79%	-15.09%	8.26%	-14.80%	9.72%	41.41%	39.78%

Insights

In beta

Mar 2017

Mar 2018

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Medical Representatives (Field Force)
count

xxx	xxx	xxx	xxx	xxx	xxx	xxx
		xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx
		xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx
		xx	xx	xx	xx	x
		xxx	xxx	xxx	xxx	xxx
		xxx	xxx	xxx	xxx	xxx
		x.xx	x.xx	x.xx	x.xx
				xxx	xxx	xxx

Please log in to see hidden values.

Chemists/Retail Outlets
count

Medical Practitioners (Doctors)
count

Number of Brands
count

Number of Products (SKUs)
count

Stockists/Distributors
count

PCPM (Per Capita Per Month)
INR lacs per MR per month

Districts of Presence
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	36.78%	37.01%	37.03%	37.03%	37.03%	37.03%	37.03%	37.03%	37.03%	40.03%	40.03%	40.03%
	63.22%	62.99%	62.97%	62.97%	62.97%	62.97%	62.99%	62.96%	62.97%	59.98%	59.97%	59.98%
No. of Shareholders	13,404	13,327	13,203	13,394	13,538	13,710	13,764	13,804	13,812	13,805	13,750	13,755

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Jun 2026
	35.01%	35.01%	35.23%	35.67%	35.74%	36.22%	36.45%	37.03%	37.03%	40.03%	40.03%
	64.99%	64.99%	64.77%	64.33%	64.26%	63.78%	63.54%	62.97%	62.99%	59.97%	59.98%
No. of Shareholders	13,880	13,618	13,511	13,392	13,295	13,406	13,579	13,203	13,764	13,750	13,755

Documents

Announcements

All

Annual reports

Concalls

Jun 2026

Transcript

AI Summary
PPT
Feb 2026

Transcript

AI Summary
PPT
Nov 2025

Transcript

AI Summary
PPT
Aug 2025

Transcript

AI Summary
PPT
May 2025

Transcript

AI Summary
PPT
Feb 2025

Transcript

AI Summary
PPT
Feb 2025

Transcript

AI Summary
PPT
Oct 2024

Transcript

AI Summary
PPT
Aug 2024

Transcript

AI Summary
PPT
May 2024

Transcript

AI Summary
PPT
Feb 2024

Transcript

AI Summary
PPT
May 2023

Transcript

AI Summary
PPT
Jan 2023

Transcript

AI Summary
PPT
Nov 2022

Transcript

AI Summary
PPT
Aug 2022

Transcript

AI Summary
PPT
May 2022

Transcript

AI Summary
PPT
Jan 2022

Transcript

AI Summary
PPT
Oct 2021

Transcript

AI Summary
PPT